The coexistence of depression with mild cognitive impairment (MCI) seems to increase the risk of dementia. However, the explanations of that relationship have been inconsistent. We investigated cognitive profiles in patients with MCI with and without depression and whether changes in depression symptoms affect cognition longitudinally.
Methods:
For the study, 161 patients with MCI were divided into a depressed group (D+) and a nondepressed group (D−). After 1 year, we redivided the original D− group into D− and newly developed depression (Dd) groups and the D+ group into improved depression (Di) and nonimproved depression (Dn) groups. Neuropsychological tests assessing depression and cognitive domains were performed at baseline and follow-up.
Results:
When age-adjusted, the D+ group showed significantly poorer performance in general cognition and some subtests regarding memory, executive function, and attention. At the 1-year follow-up, changes in the calculation test (P = .005) and Controlled Oral Word Test (COWAT; P = .048) were significantly different between groups. Only the Di group showed significant improvement in calculation. The Dn group showed significant decrement in COWAT that was significantly different from that of the Di group, which showed no significant change.
Discussion:
Patients with depression having MCI showed poorer cognitive function than nondepressed patients with MCI in some cognitive domains. Improvement in depression was related to improvement or prevention of decline in cognitive measures.
ForresterSNGalloJJSmithGSLeoutsakosJS. Patterns of neuropsychiatric symptoms in mild cognitive impairment and risk of dementia. Am J Geriatr Psychiatry. 2016;24(2):117–125.
2.
CooperCSommerladALyketsosCGLivingstonG. Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am J Psychiatry. 2015;172(4):323–334.
3.
GaoYHuangCZhaoK. Depression as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Int J Geriatr Psychiatry. 2013;28(5):441–449.
4.
PanzaFFrisardiVCapursoC. Late-life depression, mild cognitive impairment, and dementia: possible continuum?Am J Geriatr Psychiatry. 2010;18(2):98–116.
5.
ChenPGanguliMMulsantBHDeKoskyST. The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch Gen Psychiatry. 1999;56(3):261–266.
6.
IsmailZSmithEEGedaY. Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement. 2016;12(2):195–202.
7.
TsopelasCStewartRSavvaGM. Neuropathological correlates of late-life depression in older people. Br J Psychiatry. 2011;198(2):109–114.
8.
WilsonRSBoylePACapuanoAW. Late-life depression is not associated with dementia-related pathology. Neuropsychology. 2016;30(2):135–142.
9.
AlexopoulosGSMeyersBSYoungRCCampbellSSilbersweigDCharlsonM. ‘Vascular depression’ hypothesis. Arch Gen Psychiatry. 1997;54(10):915–922.
10.
NaismithSLNorrieLMMowszowskiLHickieIB. The neurobiology of depression in later-life: clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98(1):99–143.
11.
PetersenRC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–194.
12.
YoonSLeeYHanC. Usefulness of the Patient Health Questionnaire-9 for Korean medical students. Acad Psychiatry. 2014;38(6):661–667.
13.
HanCJoSAKwakJH. Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric study. Compr Psychiatry. 2008;49(2):218–223.
14.
SpitzerRLKroenkeKWilliamsJB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737–1744.
15.
KroenkeKSpitzerRLWilliamsJBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613.
16.
PetterssonABostromKBGustavssonPEkseliusL. Which instruments to support diagnosis of depression have sufficient accuracy? A systematic review. Nord J Psychiatry. 2015;69(7):497–508.
17.
FolsteinMFFolsteinSEMcHughPR. “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
18.
KangYNaDLHahnS. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997;15(2):300–308.
19.
LeeJYDong WooLChoSJ. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol. 2008;21(2):104–110.
20.
NasreddineZSPhillipsNABedirianV. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699.
21.
LeeJHLeeKULeeDY. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci. 2002;57(1):P47–P53.
22.
KangYNaDL. Seoul Neuropsychological Screening Battery (SNSB). Seoul, South Korea: Human Brain Research & Consulting Co; 2003.
HinkleDEWiersmaWJursSG. Applied Statistics for the Behavioral Sciences. Boston, MA: Houghton Mifflin; 2003.
25.
FischerCSchweizerTAAtkinsJH. Neurocognitive profiles in older adults with and without major depression. Int J Geriatr Psychiatry. 2008;23(8):851–856.
26.
LimJOhIKHanCHuhYJ. Sensitivity of cognitive tests in four cognitive domains in discriminating MDD patients from healthy controls: a meta-analysis. Int Psychogeriatr. 2013;25(9):1543–1557.
27.
HudonCVoyerPTremblayITardifSCarmichaelPH. Differentiation of the pattern of cognitive impairment between depressed and non-depressed patients with dementia living in long-term care facilities. Aging Ment Health. 2010;14(3):293–302.
28.
SteffensDCMcQuoidDRPayneMEPotterGG. Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study. Am J Geriatr Psychiatry. 2011;19(1):4–12.
29.
DonovanNJHsuDCDagleyAS. Depressive symptoms and biomarkers of Alzheimer’s disease in cognitively normal older adults. J Alzheimers Dis. 2015;46(1):63–73.
30.
McEwenBSSapolskyRM. Stress and cognitive function. Curr Opin Neurobiol. 1995;5(2):205–216.
31.
EricksonKIMillerDLRoeckleinKA. The aging hippocampus: interactions between exercise, depression, and BDNF. Neuroscientist. 2012;18(1):82–97.
32.
JehnCFBeckerBFlathB. Neurocognitive function, brain-derived neurotrophic factor (BDNF) and IL-6 levels in cancer patients with depression. J Neuroimmunol. 2015;287:88–92.
33.
FaillaMDJuengstSBArenthPMWagnerAK. Preliminary associations between brain-derived neurotrophic factor, memory impairment, functional cognition, and depressive symptoms following severe TBI. Neurorehabil Neural Repair. 2016;30(5):419–430.
34.
KaiserRHAndrews-HannaJRWagerTDPizzagalliDA. Large-scale network dysfunction in major depressive disorder: a meta-analysis of resting-state functional connectivity. JAMA Psychiatry. 2015;72(6):603–611.
35.
YangXMaXHuangB. Gray matter volume abnormalities were associated with sustained attention in unmedicated major depression. Compr Psychiatry. 2015;63:71–79.
36.
ElliottRBakerSCRogersRD. Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography. Psychol Med. 1997;27(4):931–942.
37.
OkadaGOkamotoYMorinobuSYamawakiSYokotaN. Attenuated left prefrontal activation during a verbal fluency task in patients with depression. Neuropsychobiology. 2003;47(1):21–26.
38.
WagnerGSinselESobanskiT. Cortical inefficiency in patients with unipolar depression: an event-related FMRI study with the Stroop task. Biol Psychiatry. 2006;59(10):958–965.
39.
KelleyRGarrettACohenJ. Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression. Psychiatry Res. 2013;211(2):119–126.
40.
KasselMTRaoJAWalkerSJ. Decreased fronto-limbic activation and disrupted semantic-cued list learning in major depressive disorder. J Int Neuropsychol Soc. 2016;22(4):412–425.
41.
BremnerJDVythilingamMVermettenEVaccarinoVCharneyDS. Deficits in hippocampal and anterior cingulate functioning during verbal declarative memory encoding in midlife major depression. Am J Psychiatry. 2004;161(4):637–645.
42.
BoraEHarrisonBJYucelMPantelisC. Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med. 2013;43(10):2017–2026.
43.
Herrera-GuzmanIGudayol-FerreEHerrera-AbarcaJE. Major depressive disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with major depressive disorder in recovery. J Affect Disord. 2010;123(1-3):341–350.
44.
RosenblatJDKakarRMcIntyreRS. The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials. Int J Neuropsychopharmacol. 2016;19(2). pii: pyv082.
45.
BanasrMDwyerJMDumanRS. Cell atrophy and loss in depression: reversal by antidepressant treatment. Curr Opin Cell Biol. 2011;23(6):730–737.
46.
LuoniAMacchiFPappMMolteniRRivaMA. Lurasidone exerts antidepressant properties in the chronic mild stress model through the regulation of synaptic and neuroplastic mechanisms in the rat prefrontal cortex. Int J Neuropsychopharmacol. 2014;18(4). pii: pyu061.
47.
JiangPDangRLLiHD. The impacts of swimming exercise on hippocampal expression of neurotrophic factors in rats exposed to chronic unpredictable mild stress. Evid Based Complement Alternat Med. 2014;2014:729827.
48.
YoshimuraSOkamotoYMatsunagaM. Cognitive behavioral therapy changes functional connectivity between medial prefrontal and anterior cingulate cortices. J Affect Disord. 2017;208:610–614.
49.
GorwoodPCorrubleEFalissardBGoodwinGM. Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients. Am J Psychiatry. 2008;165(6):731–739.
50.
YoonSJeonSWKoYH. Adjunctive brexpiprazole as a novel effective strategy for treating major depressive disorder: a systematic review and meta-analysis. J Clin Psychopharmacol. 2017;37(1):46–53.
51.
CuijpersPCristeaIAKaryotakiEReijndersMHuibersMJ. How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry. 2016;15(3):245–258.
52.
TatenoASakayoriTHiguchiM. Amyloid imaging with [(18)F]florbetapir in geriatric depression: early-onset versus late-onset. Int J Geriatr Psychiatry. 2015;30(7):720–728.
53.
DisabatoBMMorrisCHranilovichJ. Comparison of brain structural variables, neuropsychological factors, and treatment outcome in early-onset versus late-onset late-life depression. Am J Geriatr Psychiatry. 2014;22(10):1039–1046.
